A NULL C-MYC MUTATION CAUSES LETHALITY BEFORE 10.5 DAYS OF GESTATION IN HOMOZYGOTES AND REDUCED FERTILITY IN HETEROZYGOUS FEMALE MICE

被引:439
作者
DAVIS, AC [1 ]
WIMS, M [1 ]
SPOTTS, GD [1 ]
HANN, SR [1 ]
BRADLEY, A [1 ]
机构
[1] VANDERBILT UNIV, MED CTR, SCH MED, DEPT CELL BIOL, NASHVILLE, TN 37232 USA
关键词
C-MYC; GENE TARGETING; NULL MUTATION; EMBRYONIC LETHAL;
D O I
10.1101/gad.7.4.671
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
To directly assess c-myc function in cellular proliferation, differentiation, and embryogenesis, we have used homologous recombination in embryonic stem cells to generate both heterozygous and homozygous c-myc mutant ES cell lines. The mutation is a null allele at the protein level. Mouse chimeras from seven heterozygous cell lines transmitted the mutant allele to their offspring. The analysis of embryos from two clones has shown that the mutation is lethal in homozygotes between 9.5 and 10.5 days of gestation. The embryos are generally smaller and retarded in development compared with their littermates. Pathologic abnormalities include the heart, pericardium, neural tube, and delay or failure in turning of the embryo. Heterozygous females have reduced fertility owing to embryonic resorption before 9.5 days of gestation in 14% of implanted embryos. c-Myc protein is necessary for embryonic survival beyond 10.5 days of gestation; however, it appears to be dispensable for cell division both in ES cell lines and in the the embryo before that time.
引用
收藏
页码:671 / 682
页数:12
相关论文
共 53 条
  • [1] THE C-MYC ONCOGENE DRIVEN BY IMMUNOGLOBULIN ENHANCERS INDUCES LYMPHOID MALIGNANCY IN TRANSGENIC MICE
    ADAMS, JM
    HARRIS, AW
    PINKERT, CA
    CORCORAN, LM
    ALEXANDER, WS
    CORY, S
    PALMITER, RD
    BRINSTER, RL
    [J]. NATURE, 1985, 318 (6046) : 533 - 538
  • [2] DETERMINATION OF THE DNA-SEQUENCE RECOGNIZED BY THE BHLH-ZIP DOMAIN OF THE N-MYC PROTEIN
    ALEX, R
    SOZERI, O
    MEYER, S
    DILDROP, R
    [J]. NUCLEIC ACIDS RESEARCH, 1992, 20 (09) : 2257 - 2263
  • [3] BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733
  • [4] A BLOCK TO ELONGATION IS LARGELY RESPONSIBLE FOR DECREASED TRANSCRIPTION OF C-MYC IN DIFFERENTIATED HL60 CELLS
    BENTLEY, DL
    GROUDINE, M
    [J]. NATURE, 1986, 321 (6071) : 702 - 706
  • [5] SEQUENCE OF THE MURINE AND HUMAN CELLULAR MYC ONCOGENES AND 2 MODES OF MYC TRANSCRIPTION RESULTING FROM CHROMOSOME-TRANSLOCATION IN B-LYMPHOID TUMORS
    BERNARD, O
    CORY, S
    GERONDAKIS, S
    WEBB, E
    ADAMS, JM
    [J]. EMBO JOURNAL, 1983, 2 (12) : 2375 - 2383
  • [6] MAX - A HELIX-LOOP-HELIX ZIPPER PROTEIN THAT FORMS A SEQUENCE-SPECIFIC DNA-BINDING COMPLEX WITH MYC
    BLACKWOOD, EM
    EISENMAN, RN
    [J]. SCIENCE, 1991, 251 (4998) : 1211 - 1217
  • [7] BRADLEY A, 1987, TERATOCARCINOMAS EMB, P113
  • [8] Brown NA, 1990, POSTIMPLANTATION MAM, P93
  • [9] THE MYC ONCOGENE - ITS ROLE IN TRANSFORMATION AND DIFFERENTIATION
    COLE, MD
    [J]. ANNUAL REVIEW OF GENETICS, 1986, 20 : 361 - 384
  • [10] CONTINUED WITHDRAWAL FROM THE CELL-CYCLE AND REGULATION OF CELLULAR GENES IN MOUSE ERYTHROLEUKEMIA-CELLS BLOCKED IN DIFFERENTIATION BY THE C-MYC ONCOGENE
    COPPOLA, JA
    PARKER, JM
    SCHULER, GD
    COLE, MD
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (04) : 1714 - 1720